PHARMACEUTICAL AND BASIC MEDICAL SCIENCES II

Back

Learning Outcomes

Will be able to Evaluate Autonomic Nervous System Anatomically.
• Explains the structures forming the Trunkus sympathetic. • Explains the effects on target organs. • Explains the cranial section. • Explains the sacral section. • Explains the effects on target organs. • Explains the localization of plexus.
Will be able to Evaluate Nervous System and Autonomic Nervous System Physiologically.
Defines clinical pharmacy. Explains the history of clinical pharmacy. Explains the reasons of clinical pharmacy. Lists the differences between traditional and clinical pharmacy. Explains the scope of clinical pharmacy. Explains clinical pharmacy practices Defines the role of clinical pharmacist. Explains the benefits of clinical pharmacy services. Defines pharmaceutical care. Lists the principles of pharmaceutical care Lists the differences between clinical pharmacy and pharmaceutical care. Defines drug therapy management services. Defines rational drug use. Explains the applications of rational drug use. Lists the widespread irrational use of the drug. Defines drug related problems. Defines evidence-based medicine. Explains evidence-based medical practice. Explains the state of clinical pharmacy in the world. Describes the status of clinical pharmacy in Turkey. Explains the community pharmacy practice. Explains patient education and consulting. Explains the training and consulting checklist. Defines non-prescription drugs. Lists the differences between prescription and non-prescription drugs. Explains the pharmacist suggestions. Explains taking information and history from the patient. Explain the relationship between evidence-based medicine and non-prescription drugs.
• Explains the physiological organization of the nervous system. • Distinguishes the central nervous system. • Distinguishes the peripheral nervous system. • Explains functional parts of neuron. • Explains the concept of membrane potential • Describes the formation, propagation and functions of the action potential. • Describes synapse. • Describes synaptic organization. • Discusses the basic functions of synapses. • Lists the mediators involved in synaptic communication. • Explains the general organization of autonomic nervous system. • Explains the difference of autonomic nervous system from somatic nervous system. • Explains the concept of ganglion. • Explains the basic properties of parasympathetic nervous system. • Explains the basic features of sympathetic nervous system. • Describes autonomic reflexes. • Describes the synthesis of acetylcholine. • Describes the release of acetylcholine. • Describes the destruction of acetylcholine. • Describes acetylcholine receptors. • Explains the mechanism of action of acetylcholine. • Describes the physiological effects of acetylcholine on smooth muscle. • Describes the physiological effects of acetylcholine on the heart muscle. • Describes the physiological effects of acetylcholine on the gland. • Describes the synthesis of Noradrenaline. • Describes the release of Noradrenaline. • Describes the destruction of Noradrenaline. • Describes the receptors of Noradrenaline. • Explains the mechanism of action of Noradrenaline. • Describes the physiological effects of noradrenaline on smooth muscle. • Describes the physiological effects of noradrenaline on the heart muscle. • Explains the physiological effects of noradrenaline on the gland. • Describes the synthesis of adrenaline. • Describes the release of adrenaline. • Describes the destruction of adrenaline. • Describes the receptors of adrenaline. • Explains the mechanism of action of adrenaline. • Explains the physiological effects of adrenaline on smooth muscle. • Explains the physiological effects of adrenaline on the heart muscle. • Explains the physiological effects of adrenaline on the gland. • Describes the synthesis of dopamine. • Describes the release of dopamine. • Describes the destruction of dopamine. • Describes the receptors of dopamine. • Explains the mechanism of action of dopamine. • Explains the physiological effects of dopamine on smooth muscle. • Describes the physiological effects of dopamine on the heart muscle. • Explains the physiological effects of dopamine on the gland. • Explains non-adrenergic non-cholinergic nervous system.
Will be able to Evaluate the Pharmacological Aspects of Autonomic Nervous System Drugs.
• Explains the concept of colinomimetic. • Classifies cholinomimetic drugs. • Explains the pharmacokinetic properties of cholinomimetic drugs. • Distinguishes the mechanisms of action of cholinomimetic drugs. • Distinguishes the indications of cholinomimetic drugs. • Gives an example of cholinomimetic drugs for indications. • Describes the side effects of cholinomimetic drugs. • Explains the contraindications of cholinomimetic drugs. • Explains the concept of parasympatholytic. • Classifies parasympatholytic drugs. • Explains the pharmacokinetic properties of parasympatholytic drugs. • Distinguishes the mechanisms of action of parasympatholytic drugs. • Distinguishes the indications of parasympatholytic drugs. • Gives examples of parasympatholytic drugs for indications. • Describes the side effects of parasympatholytic drugs. • Explains contraindications of parasympatholytic drugs. • Explains the concept of sympathomimetic. • Classifies sympathomimetic drugs. • Explains pharmacokinetic properties of sympathomimetic drugs. • Distinguishes the mechanisms of action of sympathomimetic drugs. • Distinguishes the indications of sympathomimetic drugs. • Gives examples of sympathomimetic drugs for indications. • Describes the side effects of sympathomimetic drugs. • Explains the contraindications of sympathomimetic drugs. • Explains the concept of sympatholith. • Categorizes sympatholytic drugs. • Explains pharmacokinetic properties of sympatholytic drugs. • Distinguishes the mechanisms of action of sympatholytic drugs. • Distinguishes the indications of sympatholytic drugs. • Gives examples of sympatholytic drugs for the indications used. • Describes the side effects of sympatholytic drugs. • Explains the contraindications of sympatholytic drugs. • Explains the concepts of ganglion stimulation and blockade. • Classifies drugs that stimulate and block ganglia. • Explains the pharmacokinetic properties of drugs that stimulate and block ganglia. • Distinguishes the indications of ganglion stimulating drugs. • Gives examples of ganglion-stimulating drugs for indications. • Describes the side effects of ganglion stimulating drugs. • Explains the contraindications of ganglion stimulating drugs.
Will be able to Evaluate Adverse Effects of Autonomic Nervous System Drugs.
• Lists the adverse effects induced by cholinomimetic drugs. • Explains the mechanism of adverse effects induced by cholinomimetic drugs. • Explains the risk factors for adverse reactions induced by cholineomimetic drugs. • Counts drug-drug and drug-nutrient interactions. • Explains drug-drug and drug-nutrient interactions. • Lists the adverse effects induced by parasympatholytic drugs. • Explains the mechanism of adverse reactions induced by parasympatholytic drugs. • Explains the risk factors for the adverse effects induced by parasympatholytic drugs. • Counts drug-drug and drug-nutrient interactions. • Explains drug-drug and drug-nutrient interactions. • Lists the adverse effects induced by sympathomimetic drugs. • Explains the mechanism of adverse effects induced by sympathomimetic drugs. • Explains the risk factors for adverse effects induced by sympathomimetic drugs. • Lists drug-drug and drug-nutrient interactions. • Explains drug-drug and drug-nutrient interactions. • Lists the adverse effects induced by sympatholytic drugs. • Explains the mechanism of adverse effects induced by sympatholytic drugs. • Explains the risk factors of adverse effects induced by sympatholytic drugs. • Lists drug-drug and drug-nutrient interactions. • Explains drug-drug and drug-nutrient interactions. • Lists adverse effects induced by ganglion stimulants and blockers. • Describes the mechanism of adverse effects induced by ganglion stimulants and blockers. • Explains the risk factors for adverse effects induced by ganglion stimulants and blockers. • Lists drug-drug and drug-nutrient interactions. • Explains drug-drug and drug-nutrient interactions.
Will be able to Evaluate Cardiovascular and Urinary Systems Anatomically.
• Describes the location of the heart. • Lists the neighborhoods of the heart. • Lists the layers of the heart. • Lists the spaces of the heart. • Lists the coronary vessels and veins of the heart. • Lists the large vessels coming out of the heart. • Describes the heart transmission system. • Explains the aortic arch and branches. • Explains the branches of the thoracic and abdominal aorta. • Explains the upper extremity vessels. • Explains the vessels of the lower extremity. • Groups superficial and deep veins. • Lists the veins of the head and neck. • Lists the extremity veins. • Groups the portal and caval veins. • Groups lymph nodes. • Explains lymphatic drainage. • Describes the structure and structure of kidneys. • Describes the structures forming the upper urinary tract. • Describes the structures forming the lower urinary tract.
Will be able to Evaluate Cardiovascular and Urinary Systems Physiologically.
• Explains the physiology and action potentials of the heart muscle. • Distinguishes systole and diastole formation. • Analyzes the function of the ventricles as the preparatory pump of the atria. • Distinguishes the function of heart valves. • Explains the work done by the heart and the chemical energy required for it and the oxygen consumption of the heart. • Explains the intrinsic regulation-Frank Starling mechanism. • Distinguishes the effects of potassium and calcium ions on cardiac function. • Explains the specific alert and message system of the heart. • Analyzes the sinus node and the A-V node and the passage between the nodes and the signaling of the heart. • Distinguishes the delivery of ventricular purkinje system and cardiac stimulation in ventricular muscle. • Explains neural control of heart rhythm and warning message. • Defines the characteristics of normal electrocardiography and observed waves. • Analyzes the relationship between electrocardiography and heart cycle. • Explains movements around the heart during heart cycle • Explains electrocardiographic interpretation of cardiac muscle and coronary blood flow abnormalities. • Distinguishes abnormal conditions in the QRS complex. • Analyzes prolonged and complex QRS complexes. • Distinguishes between coronary ischemia as a cause of injury and its cause. • Distinguishes T wave anomalies. • Classifies tachycardia, bradycardia and sinus arrhythmia with abnormal sinus rhythms. • Explains sinoatrial block, atrioventricular block, etc. developed due to blocks occurring in warning transmission. • Categorizes atrial and ventricular origin arrhythmias. • Explains atrial and ventricular fibrillation and explain atrium flatium. • Explains ECG findings and physiological process in cardiac arrest. • Explains physical characteristics of circulation and basic theory of circulatory function • Describes differences between pressure, current and resistance. • Describes the contraction of smooth muscle. • Explains contraction with calcium ions. • Explains the neural and hormonal control of smooth muscle contraction. • Discusses the ability of the veins to stretch. • Explains the function of veins, venous pressures and storage of veins. • Analyzes the physiological function of the capillary system. • Describes the normal values of heart rate during rest and activity. • Describes control of heart rate by venous return-frank starling mechanism of the heart • Discusses pathologically high and low heart rates. • Lists the methods of measuring heart rate. • Describes local control of blood flow according to the requirements of the tissue. • Discusses the control mechanisms of blood flow. • Explains humoral control of circulation. • Explains the neural regulation of circulation. • Distinguishes the role of nervous system in rapid control of arterial pressure. • Lists the reflex mechanisms in maintaining normal arterial pressure.
Will be able to Evaluate the Pharmacological Aspects of Cardiovascular and Urinary Systems Drugs.
• Classifies antihypertensive drugs. • Explains pharmacokinetic properties of antihypertensive drugs. • Distinguishes the mechanisms of action of antihypertensive drugs. • Distinguishes the indications of antihypertensive drugs. • Gives examples of antihypertensive drugs for the indications used. • Describes the side effects of antihypertensive drugs. • Explains the contraindications of antihypertensive drugs. • Classifies peripheral vasodilator drugs. • Explains the pharmacokinetic properties of peripheral vasodilators. • Distinguishes the mechanism of action of peripheral vasodilators. • Distinguishes the indications of peripheral vasodilators. • Gives examples of peripheral vasodilator drugs for indications. • Describes the side effects of peripheral vasodilators. • Explains the contraindications of peripheral vasodilators. • Classifies the antianginal drugs. • Explains pharmacokinetic properties of antianginal drugs. • Distinguishes the mechanism of action of antianginal drugs. • Distinguish the indications of antianginal drugs. • Gives examples of antianginal drugs for indications. • Describes the side effects of antianginal drugs. • Explains contraindications of antianginal drugs. • Classifies antiarrhythmic drugs. • Explains pharmacokinetic properties of antiarrhythmic drugs. • Distinguishes the mechanisms of action of antiarrhythmic drugs. • Distinguishes the indications of antiarrhythmic drugs. • Gives examples of antiarrhythmic drugs for indications. • Describes the side effects of antiarrhythmic drugs. • Explains contraindications of antiarrhythmic drugs. • Classifies drugs used against heart failure. • Explains pharmacokinetic properties of drugs used against heart failure. • Distinguishes the mechanisms of action of drugs used against heart failure. • Distinguishes the indications of drugs used against heart failure. • Gives examples of drugs used against heart failure for indications. • Describes the side effects of drugs used against heart failure. • Explains contraindications of drugs used against heart failure. • Classifies hypolipidemic drugs. • Explains the pharmacokinetic properties of hypolipidemic drugs. • Distinguishes the mechanisms of action of hypolipidemic drugs. • Distinguishes the indications of hypolipidemic drugs. • Gives examples of hypolipidemic drugs for indications. • Describes the side effects of hypolipidemic drugs. • Explains the contraindications of hypolipidemic drugs. • Classifies anticoagulant drugs. • Explains pharmacokinetic properties of anticoagulant drugs. • Distinguishes the mechanisms of action of anticoagulant drugs. • Distinguishes the indications of anticoagulant drugs. • Gives an example of anticoagulant drugs for indications. • Explains the use of anticoagulant drugs in special patient groups. • Describes the side effects of anticoagulant drugs. • Explains the contraindications of anticoagulant drugs. • Classifies antithrombocytic drugs. • Explains pharmacokinetic properties of antithrombocytic drugs. • Distinguishes the mechanisms of action of antithrombocytic drugs. • Distinguishes the indications of antithrombocytic drugs. • Gives examples of antithrombocytic drugs for indications. • Explains the use of antithrombocytic drugs in special patient groups. • Describes the side effects of antithrombocytic drugs. • Explains contraindications of antithrombocytic drugs. • Classifies thrombolytic drugs. • Explains pharmacokinetic properties of thrombolytic drugs. • Distinguishes the mechanisms of action of thrombolytic drugs. • Distinguishes the indications of thrombolytic drugs. • Gives examples of thrombolytic drugs for indications. • Explains the use of thrombolytic drugs in special patient groups. • Describes the side effects of thrombolytic drugs. • Explains the contraindications of thrombolytic drugs. • Lists hemostatic drugs and hemostatic blood products used for replacement • Explains the application properties of haemostatic drugs and hemostatic blood products used for replacement. • Distinguishes the mechanisms of action of haemostatic drugs and hemostatic blood products used for replacement • Distinguishes between hemostatic drugs and hemostatic blood products used for replacement. • Gives examples of hemostatic drugs and hemostatic blood products for replacement for indications. • Explains the side effects of hemostatic drugs and the use of hemostatic blood products used for replacement. • Classifies blood plasma products, solutions that expand the plasma volume. • lists the properties of blood plasma products and solutions that extend the volume of plasma. • Distinguishes the use of blood, plasma products and solutions that extend the plasma volume. • Gives examples of blood plasma products for indications used, and solutions that extend the plasma volume. • Describes the side effects of blood plasma products and solutions that extend the plasma volume. • Classifies antianemic drugs. • Explains the properties of antianemic drugs. • Explains the pharmacokinetic properties of antianemic drugs. • Distinguishes the mechanism of action of antianemic drugs. • Distinguishes the indications of antianemic drugs. • Indicates antianemic drugs for indications. • Explains the use of antianemic drugs in special patient groups. • Describes the side effects of antianemic drugs. • Explains contraindications of antianemic drugs. • Classifies drugs affecting water, salt and acid-base balance. • Explains pharmacokinetic properties of drugs affecting water, salt and acid-base balance. • Explains the mechanism of action of drugs affecting water, salt and acid-base balance. • Distinguishes between water, salt and acid-base drugs. • Gives examples of drugs that affect water, salt and acid-base balance for the indications used. • Describes the side effects of drugs that affect water, salt and acid-base balance.
Will be able to Evaluate Adverse Effects of Cardiovascular and Urinary Systems Drugs.
• Lists the adverse effects induced by antihypertensive drugs. • Explains the mechanism of adverse effects induced by antihypertensive drugs. • Explain the risk factors for adverse effects induced by antihypertensive drugs. • Lists drug-drug and drug-nutrient interactions. • Explains drug-drug and drug-nutrient interactions. • Lists adverse effects induced by peripheral vasodilator drugs. • Explains the mechanism of adverse effects induced by peripheral vasodilator drugs. • Explains the risk factors for adverse effects induced by peripheral vasodilator drugs. • Lists drug-drug and drug-nutrient interactions. • Explains drug-drug and drug-nutrient interactions. • Lists the adverse effects induced by antianginal drugs. • Explains the mechanism of antianginal drugs induced adverse effects. • Explains the risk factors for antianginal drugs induced adverse effects. • Lists drug-drug and drug-nutrient interactions. • Explains drug-drug and drug-nutrient interactions. • Lists the adverse effects induced by antiarrhythmic drugs. • Explains the mechanism of adverse effects induced by antiarrhythmic drugs. • Explains the risk factors of adverse effects induced by antiarrhythmic drugs. • Lists drug-drug and drug-nutrient interactions. • Explains drug-drug and drug-nutrient interactions. • Lists the adverse effects induced by drugs used in the treatment of heart failure. • Explains the mechanism of adverse effects induced by drugs used in the treatment of heart failure. • Explains the risk factors for adverse effects induced by drugs used in the treatment of heart failure. • Lists drug-drug and drug-nutrient interactions. • Explains drug-drug and drug-nutrient interactions. • Lists the adverse effects induced by hypolipidemic drugs. • Explains the mechanism of adverse effects induced by hypolipidemic drugs. • Explains the risk factors of adverse effects induced by hypolipidemic drugs. • Lists drug-drug and drug-nutrient interactions. • Explains drug-drug and drug-nutrient interactions. • Lists the adverse effects induced by anticoagulant drugs. • Explains the mechanism of adverse effects induced by anticoagulant drugs. • Explains the risk factors of adverse effects induced by anticoagulant drugs. • Lists drug-drug and drug-nutrient interactions. • Explains drug-drug and drug-nutrient interactions. • Lists the adverse effects induced by antithrombocytic drugs. • Explains the mechanism of adverse effects induced by antithrombocytic drugs. • Explains the risk factors for antitrombocytic drugs induced adverse effects. • Lists drug-drug and drug-nutrient interactions. • Explains drug-drug and drug-nutrient interactions. • Lists the adverse effects induced by thrombolytic drugs. • Explains the mechanism of adverse effects induced by thrombolytic drugs. • Explains the risk factors for the adverse effects induced by thrombolytic drugs. • Lists drug-drug and drug-nutrient interactions. • Explains drug-drug and drug-nutrient interactions. • Lists the adverse effects induced by hemostatic drugs and other hemostatic blood products used for replacement. • Explains the mechanism of hemostatic drugs and adverse effects induced by replacement and other hemostatic blood products. • Explains the risk factors for hemostatic drugs and adverse reactions induced by replacement and other hemostatic blood products. • Lists drug-drug and drug-nutrient interactions. • Explains drug-drug and drug-nutrient interactions. • Lists the adverse effects induced by solutions that extend blood, plasma products and plasma volume. • Explains the mechanism of adverse events induced by solutions that extend blood, plasma products and plasma volume. • Explains the risk factors for adverse effects induced by solutions that extend blood, plasma products and plasma volume. • Lists drug-drug and drug-nutrient interactions. • Explains drug-drug and drug-nutrient interactions.• Lists the adverse effects induced by antianemic drugs. • Explains the mechanism of adverse effects induced by antianemic drugs. • Explain the risk factors for adverse effects induced by antianemic drugs. • Lists drug-drug and drug-nutrient interactions. • Explains drug-drug and drug-nutrient interactions. • Lists the adverse effects induced by drugs affecting water, salt and acid-base balance. • Explains the mechanism of adverse effects induced by drugs affecting water, salt and acid-base balance. • Explains the risk factors for adverse effects induced by drugs affecting water, salt and acid-base balance. • Lists drug-drug and drug-nutrient interactions. • Explains drug-drug and drug-nutrient interactions.
Will be able to Evaluate the Importance of Public Health.
• Explains the history of health. • Defines the concept of health. • Explains the concept of health. • Defines the public health science. • Lists the periods of medical science. • Explains the periods of medical science. • Lists the principles of the Alma-Ata declaration. • Explains the principles of Alma-Ata declaration. • Defines the concept of social goodness. • Explains the concept of social goodness. • Explains general concepts related to noncommunicable diseases. • Explains the incidence of noncommunicable diseases. • Classifies noncommunicable diseases. • Defines the concept of the burden of disease. • Lists diseases that cause disease burden in the world and in our country. • Defines the concept of DALY. • Explains the components of the DALY concept. • Explains the concept of immunization. • Explains the concepts related to immunization. • Explains the purpose of immunization. • Lists vaccine-preventable diseases. • Explain sthe concept of extended immunization program. • Lists the points to be considered in vaccination practices. • Lists contraindications of vaccines. • Explains contraindications of vaccines. • Lists the side effects of vaccines. • Explains the side effects of vaccines. • Lists situations that do not prevent vaccination. • Explains situations that do not prevent vaccination. • Defines the surveillance system. • Explains the surveillance system. • Categorizes disease control programs. • Explains the disease control programs. • Explains additional vaccination activities. • Explains the concept of cold chain. • Lists the points to be considered in cold chain applications. • Defines the components of environmental concept. • Explains the components of environmental concept. • Defines the concepts related to environmental health. • Explains the relationship between health and environment. • Explains the effects of environmental events on human health. • Categorizes the negative effects of environmental events on human health. • Explains the negative effects of environmental events on human health. • Explains the concepts related to ecology. • Lists the elements or substances that are important for living world / bioecology. • Defines the carbon cycle. • Explains the carbon cycle. • Defines the nitrogen cycle. • Describes the nitrogen cycle. • Defines the phosphorus cycle. • Explains phosphorus cycle. • Defines the sulfur cycle. • Describes the sulfur cycle. • Defines the water cycle. • Describes the water cycle. • Definex the food chain. • Explainx the food chain. • Explains the processes of converting inorganic-organic substances to each other. • Defines the concept of autopuration. • Explains the concept of autopuration. • Categorizes the mechanisms of autopuration. • Explains the mechanisms of autopuration. • Explains the concept of pollution. • Classifies the causes of pollution. • Explains the causes of pollution. • Explains the causes of pollution by sampling. • Defines environmental pollution. • Explains the factors of environmental pollution. • Explains acid rainfall. • Explains the effects of acid rainfall. • Describes the greenhouse effect. • Explains the greenhouse effect. • Explains the factors that cause the ozone layer to be punctured. • Explains the effects of ozone layer perforation. • Defines the concept of eutrophication. • Explains the concept of eutrophication. • Defines the concept of erosion. • Explains the concept of erosion. • Explains the effects of erosion. • Classifies the ways of environmental protection. • Explains the ways of environmental protection. • Categorizes the principles of environmental protection. • Classifies environmental protection equipment. • Explains the means of environmental protection. • Lists the basic requirements for the prevention of environmental pollution. • Categorizes the components of the struggle against local environmental health problems. • Explains the components of the fight against local environmental health problems. • Explains the provision of adequate and clean water. • Defines the concepts related to the provision of adequate and clean water. • Explains the harm of solid and liquid wastes. • Defines the concepts related to the destruction of solid and liquid wastes. • Explains food control and sanitation. • Defines concepts related to food control and sanitation. • Defines the concept of epidemiology. • Explains the concept of epidemiology. • Defines the concept of etiology. • Explains the concept of etiology. • Explains the history of etiology. • Categorizes the functions of epidemiology. • Explains the function of epidemiology to identify diseases. • Defines the concepts related to epidemiology of disease identification function. • Explains what to do about the disease defined by using epidemiological methods. • Explains the function of epidemiology to define society. • Defines the concepts related to the function of defining the society of epidemiology. • Explains what to do about the society defined by using epidemiological methods. • Classifies epidemiological research methods. • Describes the methods of epidemiological research. • Explains epidemiological research methods. • Describes the characteristics of person, place and time. • Explains epidemiological research methods. • Defines the concepts used as health criteria. • Explains the concepts used as health criteria. • Explains the concepts used as health criteria. • Defines the concepts that express the disease level. • Explains the concepts that express the disease level. • Explains the concepts that express the level of disease. • Defines concepts related to work and work. • Lists the working objectives of individuals. • Explains the historical development of employee health. • Defines the concept of employee health. • Explains the concept of employee health. • Defines the concept of occupational health. • Explains the concept of occupational health. • Defines the concept of occupational medicine. • Explains the concept of occupational medicine. • Defines the concept of occupational hygiene. • Explains the concept of occupational hygiene. • Defines the concept of occupational safety. • Explains the concept of occupational safety. • Defines the concept of ergonomics. • Explains the concept of ergonomics. • Explains the concepts of labor law and education. • Lists the aims of occupational health. • Explains the importance of employee health. • Lists the risk group more sensitive to factors in the work environment. • Explains the incidence of occupational accidents. • Explains the mortality and morbidity rates of occupational accidents. • Defines the work accident. • Lists the types of occupational accidents. • Categorizes the causes of occupational accidents. • Explains the causes of occupational accidents. • Explains the economic dimensions of occupational accidents. • Defines occupational accident criteria. • Defines the concept of occupational disease. • Give examples of occupational diseases. • Explains the differences between occupational disease and business disease. • Exemplifies occupational diseases. • Lists the general characteristics of occupational diseases. • Explains the general characteristics of occupational diseases. • Explains the concepts related to occupational diseases. • Defines the term of liability period. • Defines the concept of exposure time. • Explains the term of liability period by sampling. • Explains the concept of exposure time. • Lists the most common diseases in health care workers. • Classifies occupational diseases. • Gives examples of occupational diseases classes. • Explains exposure periods according to occupational diseases classes. • Explains the importance of protection from occupational accidents and occupational diseases. • Explains the concepts related to risk assessment. • Lists the control hierarchy of risks. • Classifies the approach to protection from occupational diseases. • Classifies medical applications in occupational disease prevention approach. • Explains medical practices in occupational disease prevention approach. • Classifies technical applications in occupational disease prevention approach. • Explains technical applications in occupational disease prevention approach. • Explains statistics in terms of employee health. • Explains legal regulations in terms of employee health. • Lists the important regulations in our country in terms of employee health. • Defines the concept of health promotion. • Explains the history of studies related to health promotion. • Explains the concept of health promotion. • Lists basic health services. • Explains the concept of health for everyone. • Lists the goals of health for everyone. • Explains turning points in health promotion. • Lists prerequisites for health according to the Ottawa Declaration. • Explains the preconditions of health according to the Ottawa Declaration. • Lists priority action areas for health promotion according to the Ottawa Declaration. • Describes priority action areas in health promotion according to the Ottawa Declaration. • Lists the health prerequisites according to the Adelaide Health Promotion Conference. • Explains the prerequisites for health according to the Adelaide Health Promotion Conference. • Considers health promotion strategies and what needs to be done according to the Milan Declaration. • Describes health promotion strategies and what needs to be done in accordance with the Milan Declaration. • Lists health promotion strategies according to the Sundsvall Health Promotion Conference. • Explains health promotion strategies according to Sundsvall Health Promotion Conference. • Lists health promotion strategies according to the Jakarta Health Promotion Declaration. • Explains health promotion strategies according to Jakarta Health Promotion Declaration. • Lists health promotion strategies according to the Mexico City Health Promotion Conference. • Explains health promotion strategies according to the Mexico City Health Promotion Conference. • Lists health promotion strategies according to the Bangkok Health Promotion Conference and Declaration. • Explains health promotion strategies according to the Bangkok Health Promotion Conference and Declaration. • Lists health promotion strategies according to the Nairobi Health Promotion Conference. • Explains health promotion strategies according to the Nairobi Health Promotion Conference. • Lists health goals in all policies according to the Helsinki Health Promotion Conference. • Explains health goals in all policies according to the Helsinki Health Promotion Conference. • Lists health promotion goals according to the Shanghai Health Promotion Conference. • Explains health promotion objectives according to the Shanghai Health Promotion Conference. • Lists health promotion objectives according to the Shanghai Health Promotion Conference. • Explains health promotion objectives according to the Shanghai Health Promotion Conference. • Lists the World Health Organization's programs and projects in the implementation of health promotion strategies and programs. • Explains the World Health Organization's programs and projects in the implementation of health promotion strategies and programs. • Gives examples to the cities, municipalities, villages and islands of our country which participate in the programs and projects of the World Health Organization. • Defines the concept of health behavior. • Explains the concept of health behavior. • Classifies the determinants responsible for health-related risk-taking behaviors. • Defines the concepts related to health education. • Explains the concepts related to health education. • Categorizes health education methods. • Explains health education methods. • Classifies health education tools. • Lists health education tools. • Considers what should be considered in the selection of the subject for health education. • Explains the issues to be taken into consideration in the selection of topics for health education. • Lists the groups to be trained in health education. • Lists health education. • Lists the criteria that show the health level of the community. • Explains the unusual situation. • Explains the duties and responsibilities of pharmacist in exceptional cases. • Explains the drug supply process in exceptional cases. • Lists public institutions and organizations responsible for extraordinary cases. • Defines disasters in terms of health practices and services to be provided. • Explains disaster medicine. • Explains the concept of triage.
Will be able to Evaluate General Concepts Related to Clinical Pharmacy.
Defines clinical pharmacy. Explains the history of clinical pharmacy. Explains the reasons of clinical pharmacy. Lists the differences between traditional and clinical pharmacy. Explains the scope of clinical pharmacy. Explains clinical pharmacy practices Defines the role of clinical pharmacist. Explains the benefits of clinical pharmacy services. Defines pharmaceutical care. Lists the principles of pharmaceutical care Lists the differences between clinical pharmacy and pharmaceutical care. Defines drug therapy management services. Defines rational drug use. Explains the applications of rational drug use. Lists the widespread irrational use of the drug. Defines drug related problems. Defines evidence-based medicine. Explains evidence-based medical practice. Explains the state of clinical pharmacy in the world. Describes the status of clinical pharmacy in Turkey. Explains the community pharmacy practice. Explains patient education and consulting. Explains the training and consulting checklist. Defines non-prescription drugs. Lists the differences between prescription and non-prescription drugs. Explains the pharmacist suggestions. Explains taking information and history from the patient. Explain the relationship between evidence-based medicine and non-prescription drugs.
Will be able to Evaluate Some Diseases Related to Autonomic Nervous System in terms of Clinical Pharmacy.
• Defines glaucoma. • Explain the etiology of glaucoma. • Explains the pathophysiology of glaucoma. • Describes the clinical picture of glaucoma. • Explain the diagnosis of glaucoma. • Describes glaucoma treatment. • Describes treatment targets. • Explains the treatment general approach. • Explains the dosage, administration, indications, contraindications, side effects of drugs used in the treatment of glaucoma. • Describes the evaluation of treatment outcomes. • Exemplifies by case presentation. • Defines myasthenia gravity. • Explains the etiology of myasthenia gravis. • Explains the pathophysiology of myasthenia gravis. • Describes the clinical picture of myasthenia gravis. • Explains the diagnosis of myasthenia gravis. • Describes myasthenia gravis treatment. • Describes treatment targets. • Explains the treatment general approach. • Explains the dosage, administration, indications, contraindications, side effects of drugs used in the treatment of myasthenia gravis. • Describes the evaluation of treatment outcomes. • Exemplifies by case presentation.
Will be able to Evaluate of Some Disorders Associated with Bones and Joints in terms of Clinical Pharmacy.
• Defines gout and hyperuricemia. • Explains the etiology of hyperuricemia. • Explains the pathophysiology of hyperuricemia. • Describes the clinical picture of gout and hyperuricemia. • Explains the diagnosis of gout and hyperuricemia. • Describes the treatment of acute gout arthritis. • Describes the treatment of Gutta Hyperuricemia. • Describes treatment targets. • Explains the treatment general approach. • Explains the dosage, administration, indications, contraindications, side effects of drugs used in the treatment of gout and hyperuricemia. • Describes the evaluation of treatment outcomes. • Exemplifies by case presentation. • Defines osteoporosis. • Explain the etiology of osteoporosis. • Explains the pathophysiology of osteoporosis. • Describes the clinical picture of osteoporosis. • Explains the diagnosis of osteoporosis. • Describes the treatment of osteoporosis. • Describes treatment targets. • Explains the treatment general approach. • Explains the dosage, administration, indications, contraindications, side effects of drugs used in the treatment of osteoporosis. • Describes the evaluation of treatment outcomes. • Exemplifies by case presentation. • Defines osteoarthritis. • Explains the etiology of osteoarthritis. • Explains the pathophysiology of osteoarthritis. • Explains the clinical picture of osteoarthritis. • Explains the diagnosis of osteoarthritis. • Describes treatment of osteoarthritis. • Describes treatment targets. • Explains the treatment general approach. • Explains the dosage, administration, indications, contraindications, side effects of drugs used in the treatment of osteoarthritis. • Describes the evaluation of treatment outcomes. • Exemplifies by case presentation. • Describes rheumatoid aritrite. • Explains the etiology of rheumatoid aritrite. • Describes the pathophysiology of rheumatoid aritrite. • Describes the clinical picture of rheumatoid arthritis. • Explains the diagnosis of rheumatoid arythitis. • Describes the treatment of rheumatoid aritrite. • Describes treatment targets. • Explains the treatment general approach. • Explains the dosage, administration, indications, contraindications, side effects of drugs used in the treatment of rheumatoid arythitis. • Describes the evaluation of treatment outcomes. • Exemplifies by case presentation.
Will be able to Evaluate Major Dermatological Disorders in terms of Clinical Pharmacy.
• Defines Acne Vulgaris. • Explains the Etiology of Acne Vulgaris. • Explains the Pathophysiology of Acne Vulgaris. • Describes the clinical picture of Acne Vulgaris. • Explains the diagnosis of Acne Vulgaris. • Describes Acne Vulgaris Treatment. • Explains Treatment Goals. • Explains the General Approach of Treatment. • Explains dose, method of administration, indication, contraindication and side effects of drugs used in the treatment of Acne Vulgaris; • Tells the Evaluation of Treatment Outcomes. • Gives examples with a Case Report. • Defines Skin Drug Reactions. • Explains the Pathophysiology of Skin Drug Reactions. • Describes the clinical picture of Skin Drug Reactions. • Describes the Treatment of Skin Drug Reactions. • Explains dose, method of administration, indication, contraindication and side effects of drugs used in the treatment of Skin Drug Reactions • Defines contact dermatitis. • Explains the Etiology of Contact Dermatitis. • Explains the Pathophysiology of Contact Dermatitis. • Describes the clinical picture of Contact Dermatitis. • Explains the diagnosis of Contact Dermatitis. • Describes the Treatment of Contact Dermatitis. • Explains Treatment Goals. • Explains the General Approach of Treatment. • Explains dose, method of administration, indication, contraindication and side effects of drugs used in the treatment of Contact Dermatitis. • Defines Atopic Dermatitis. • Explains the Etiology of Atopic Dermatitis. • Explains the Pathophysiology of Atopic Dermatitis. • Describes the clinical picture of Atopic Dermatitis. • Explains the diagnosis of Atopic Dermatitis. • Describes Atopic Dermatitis Treatment. • Explains Treatment Goals. • Explains the General Approach of Treatment. • Explains dose, method of administration, indication, contraindication and side effects of drugs used in the treatment of Atopic Dermatitis. • Tells the Evaluation of Treatment Outcomes. • Gives examples with a Case Report. • Defines psoriasis. • Explains the etiology of psoriasis. • Explains the pathophysiology of psoriasis. • Describes the clinical picture of psoriasis. • Explains the diagnosis of psoriasis. • Describes Psoriasis Treatment. • Explains Treatment Goals. • Explains the General Approach of Treatment. • Explains dose, method of administration, indication, contraindication and side effects of drugs used in the treatment of psoriasis. • Tells the Evaluation of Treatment Outcomes.